Mediterranean Journal of Infection Microbes and Antimicrobials

Scope & Guideline

Exploring the intricate world of microbes and health.

Introduction

Delve into the academic richness of Mediterranean Journal of Infection Microbes and Antimicrobials with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN2147-673x
PublisherGALENOS PUBL HOUSE
Support Open AccessYes
CountryTurkey
TypeJournal
Convergefrom 2018 to 2023
AbbreviationMEDITERR J INFECT M / Mediterr. J. Infect. Microbes Antimicrob.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressKacamak Sokak 21/1, ISTANBUL, Findikzade 34093, TURKIYE

Aims and Scopes

The Mediterranean Journal of Infection Microbes and Antimicrobials focuses on advancing knowledge in the fields of infectious diseases, microbiology, and antimicrobial therapy. It aims to provide a platform for researchers and clinicians to share their findings and insights related to various pathogens, treatment methodologies, and epidemiological trends.
  1. Infectious Disease Epidemiology:
    Research articles examining the prevalence, risk factors, and outcomes associated with infectious diseases across diverse populations, particularly in the Mediterranean region.
  2. Microbial Pathogenesis and Resistance:
    Studies exploring the mechanisms of pathogenicity of microorganisms, as well as their resistance patterns to antibiotics and antifungals, contributing to the understanding of treatment challenges.
  3. Clinical Microbiology and Diagnostics:
    Papers focused on laboratory diagnostics, including innovative techniques for identifying pathogens and evaluating their antimicrobial susceptibility, which are crucial for effective treatment strategies.
  4. Therapeutic Interventions and Outcomes:
    Research evaluating the efficacy and safety of various therapeutic interventions for infectious diseases, including novel antibiotics, antiviral agents, and antifungal therapies.
  5. Emerging Infections and Public Health:
    Investigations into new and re-emerging infections, their impact on public health, and the responses required to manage outbreaks, especially in the context of global health challenges.
The journal has witnessed a rise in interest in several key areas that reflect current global health challenges and advancements in research methodologies. These emerging themes signify a response to evolving infectious disease landscapes.
  1. COVID-19 Research:
    A significant increase in studies related to COVID-19, including epidemiology, clinical outcomes, and vaccine efficacy, reflects the urgent need to understand and combat this global pandemic.
  2. Antimicrobial Stewardship:
    Emerging research on antimicrobial stewardship practices highlights efforts to optimize the use of antibiotics and antifungals in clinical settings, aiming to combat the growing threat of resistance.
  3. Fungal Infections and Antifungal Resistance:
    There is a notable uptick in research focused on invasive fungal infections and their management, particularly in immunocompromised patients, as well as studies addressing antifungal resistance patterns.
  4. Artificial Intelligence in Diagnostics:
    The integration of artificial intelligence and machine learning in the diagnosis and management of infections is becoming increasingly prevalent, indicating a trend toward leveraging technology for improved patient care.
  5. Global Health Perspectives:
    Research incorporating global health perspectives, particularly in relation to infectious disease outbreaks and their socio-economic impacts, is gaining traction, reflecting an interdisciplinary approach to public health.

Declining or Waning

While the journal maintains a broad focus, certain themes have shown a decline in prominence in recent years. This may reflect shifting research priorities or a saturation of studies in these areas.
  1. Traditional Antibiotic Therapy:
    There has been a noticeable decrease in studies focusing solely on traditional antibiotics without considering newer agents or combination therapies, as the field increasingly shifts toward addressing antibiotic resistance and exploring innovative treatment options.
  2. Non-communicable Disease Infections:
    Research on infections related to non-communicable diseases appears to be waning, possibly due to a greater emphasis on acute infectious diseases, especially in light of recent global health crises.
  3. Basic Laboratory Techniques:
    Papers detailing basic laboratory methodologies and techniques may be declining as the field moves towards more advanced and automated diagnostic methods, reflecting a shift in research focus towards clinical applications and outcomes.

Similar Journals

European Journal of Microbiology and Immunology

Pioneering Research for a Healthier Tomorrow
Publisher: AKADEMIAI KIADO ZRTISSN: 2062-8633Frequency: 4 issues/year

Welcome to the European Journal of Microbiology and Immunology, a premier platform dedicated to advancing the field of microbiology and immunology through the dissemination of high-quality research. Published by AKADEMIAI KIADO ZRT in Hungary, this journal serves as an essential resource for researchers, professionals, and students alike, fostering scholarly communication and innovation in these critical areas of medical science. The journal, which holds an ISSN of 2062-8633, presents rigorously peer-reviewed articles that contribute to our understanding of microbial diseases, immune responses, and related fields, currently ranking in the Q2 and Q3 quartiles across multiple categories such as immunology and microbiology. By embracing an inclusive scholarly dialogue and offering a robust readership, the European Journal of Microbiology and Immunology aims to inspire the next wave of discoveries and collaborations within the global scientific community.

Indian Journal of Medical Microbiology

Connecting Global Scholars in Microbiology and Infectious Diseases
Publisher: ELSEVIERISSN: 0255-0857Frequency: 4 issues/year

Indian Journal of Medical Microbiology, published by Elsevier, is a pivotal peer-reviewed journal dedicated to the field of medical microbiology, providing a vital platform for research and scholarship since its inception in 1986. With an Open Access model established in 2001, it ensures the dissemination of scientific knowledge to a global audience, enhancing accessibility for researchers, professionals, and students alike. The journal's scope spans critical areas including immunology, infectious diseases, and microbiology, with an impressive trajectory marked by converged years of publication allowing for a comprehensive exploration of evolving scientific trends. As of 2023, the journal holds a Q3 ranking in Infectious Diseases and Microbiology (medical) and a Q4 ranking in Immunology and Microbiology categories, reflecting its significant yet growing impact in the field. Researchers seeking to contribute to or stay updated on the latest advancements in medical microbiology will find the Indian Journal of Medical Microbiology a valuable resource, as it consistently bridges the gap between emerging science and clinical application.

Microbiology Spectrum

Bridging disciplines in the realm of microbiological studies.
Publisher: AMER SOC MICROBIOLOGYISSN: 2165-0497Frequency: 6 issues/year

Microbiology Spectrum is a prominent peer-reviewed journal published by the American Society for Microbiology, dedicated to advancing the field of microbiology through the dissemination of high-quality research. Since its inception in 2013 and continuing until 2024, the journal has established a strong presence in key domains such as microbiology, immunology, cell biology, and ecology, achieving impressive quartile rankings including Q1 in Infectious Diseases and Q1 in Immunology and Microbiology as of 2023. With an emphasis on open access to its scholarly content, Microbiology Spectrum aims to foster collaboration and knowledge sharing among researchers, professionals, and students alike. The journal's scope encompasses a diverse range of topics pertinent to the field, making it an essential resource for anyone involved in microbiological research and its applications. Researchers looking to publish their findings in a respected journal will find Microbiology Spectrum's robust impact factor and Scopus rankings serve as testament to its significance and influence within the academic community.

COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES

Advancing Knowledge in Immunology and Microbiology
Publisher: ELSEVIER SCI LTDISSN: 0147-9571Frequency: 6 issues/year

Comparative Immunology Microbiology and Infectious Diseases, published by Elsevier Science Ltd, is a prominent journal dedicated to advancing the fields of immunology, microbiology, infectious diseases, and veterinary sciences. Established in 1978, this journal has become a vital resource for researchers and professionals alike, with a commendable impact factor that reflects its significance in academia. The journal, available in both print and electronic formats (ISSN: 0147-9571, E-ISSN: 1878-1667), stands out for its commitment to disseminating innovative research findings, particularly through its categorization in Q2 and Q3 quartiles across various related disciplines as of 2023. The journal aims to provide insightful comparative analyses that enhance our understanding of host-pathogen interactions, immune responses, and disease manifestations. With a global readership base, it serves as a platform for collaborative discourse among scientists and professionals, ultimately contributing to the improvement of health outcomes worldwide.

JOURNAL OF CLINICAL MICROBIOLOGY

Transforming Knowledge into Clinical Practice
Publisher: AMER SOC MICROBIOLOGYISSN: 0095-1137Frequency: 12 issues/year

JOURNAL OF CLINICAL MICROBIOLOGY, published by the American Society for Microbiology, stands as a premier resource for researchers and professionals in the field of medical microbiology. With an illustrious history dating back to 1975, this journal has consistently provided high-impact research, reflecting its status in the Q1 category among microbiology (medical) journals, and an impressive Scopus rank of 14 out of 140, placing it in the 90th percentile. The journal's commitment to unveiling foundational and innovative studies greatly contributes to understanding human health challenges posed by microbial pathogens. Researchers can expect rigorous peer-reviewed articles that cover a spectrum of topics, from diagnostic methods to clinical epidemiology, fostering a deeper understanding of microbiology's role in healthcare. While this journal does not offer open access options, its substantial impact factor underscores its relevance in shaping the conversation in clinical microbiology. The JOURNAL OF CLINICAL MICROBIOLOGY is indispensable for anyone dedicated to advancing their knowledge and practical skills in microbiology.

MICROBES AND INFECTION

Unveiling the Secrets of Microbial Behavior
Publisher: ELSEVIERISSN: 1286-4579Frequency: 12 issues/year

MICROBES AND INFECTION is a premier academic journal published by Elsevier, dedicated to the dynamic fields of immunology, infectious diseases, and microbiology. With a notable impact factor reflective of its high-quality research contributions, the journal is categorized in the Q2 quartile across these fields as of 2023. Based in France and operating since 1999, MICROBES AND INFECTION offers a platform for researchers, professionals, and students to disseminate and access cutting-edge findings that drive innovation and knowledge in microbial and infectious disease research. The journal is ranked impressively within the Scopus database, securing ranks such as #16 in Microbiology and #33 in Infectious Diseases, underscoring its high relevance in the scientific community. Subscribers to the journal can expect an array of articles, reviews, and original research, all designed to advance understanding and improve clinical practices in the fight against infectious agents. With its ongoing commitment to open access options, MICROBES AND INFECTION continues to foster global collaboration and information sharing in the pursuit of addressing pressing microbiological challenges.

CLINICAL MICROBIOLOGY AND INFECTION

Advancing the Science of Infection
Publisher: ELSEVIER SCI LTDISSN: 1198-743XFrequency: 12 issues/year

CLINICAL MICROBIOLOGY AND INFECTION is a leading journal published by Elsevier Science Ltd, dedicated to advancing the field of infectious diseases and clinical microbiology. With its ISSN 1198-743X and E-ISSN 1469-0691, this esteemed journal has maintained its influential presence since 1995, showcasing high-impact research that addresses critical issues in the diagnosis, treatment, and prevention of infections. Ranked in the Q1 quartile for Infectious Diseases, Medicine (miscellaneous), and Microbiology (medical) categories, and boasting impressive Scopus rankings of #12 and #7 respectively, it sits at the forefront of scientific inquiry in these disciplines. Although it is not an Open Access journal, it provides comprehensive access options for institutions and individuals, ensuring the dissemination of vital research findings. As the field of clinical microbiology continues to evolve, CLINICAL MICROBIOLOGY AND INFECTION remains an essential resource for researchers, clinicians, and students aiming to stay informed on the latest developments and breakthroughs in understanding infectious diseases.

CLINICAL MICROBIOLOGY REVIEWS

Empowering healthcare with cutting-edge research.
Publisher: AMER SOC MICROBIOLOGYISSN: 0893-8512Frequency: 4 issues/year

CLINICAL MICROBIOLOGY REVIEWS, published by the American Society for Microbiology, is a leading journal in the fields of epidemiology, immunology, and microbiology, notably recognized for its Q1 status in multiple categories such as Infectious Diseases and Public Health. With an ISSN of 0893-8512 and E-ISSN of 1098-6618, this esteemed journal offers comprehensive reviews and analyses that contribute to the advancement of clinical microbiology practices worldwide. Since its inception in 1988, it has established itself as a pivotal resource for researchers and healthcare professionals, delivering high-quality, peer-reviewed articles that are instrumental in understanding microbial diseases. The journal is highly regarded in the academic community, boasting impressive Scopus rankings, including Rank #1 in Medical Microbiology and a commendable 99th percentile in Public Health. Although not available as an open-access publication, CLINICAL MICROBIOLOGY REVIEWS remains an essential tool for those seeking to enhance their knowledge and practice in microbiology, making significant impacts on clinical outcomes and public health initiatives.

Lancet Microbe

Advancing the Frontiers of Microbial Research
Publisher: ELSEVIERISSN: Frequency: 12 issues/year

The Lancet Microbe is a leading peer-reviewed journal published by ELSEVIER, focused on advancing research in the fields of infectious diseases, microbiology, and virology. Since its inception in 2020, this open-access journal has rapidly achieved a prestigious reputation, evidenced by its impressive rankings in the Scopus Ranks, where it holds positions within the top 10 in multiple categories and boasts high percentiles, reflecting the impact and relevance of its published works. With a quarterly publication schedule, the Lancet Microbe aims to disseminate critical findings and foster innovation within the scientific community, providing a platform for researchers and professionals to share their significant contributions. The journal is committed to facilitating knowledge exchange and accessibility, making it an essential resource for academicians and practitioners dedicated to addressing global health challenges.

Frontiers in Cellular and Infection Microbiology

Empowering science through open access innovation.
Publisher: FRONTIERS MEDIA SAISSN: 2235-2988Frequency: 1 issue/year

Frontiers in Cellular and Infection Microbiology, published by FRONTIERS MEDIA SA, is a leading Open Access journal that has been at the forefront of microbiological research since 2011. Located in Switzerland, this journal aims to provide a platform for innovative and impactful studies in various domains including immunology, infectious diseases, and medical microbiology. With an impressive range of quartile rankings—Q1 in Infectious Diseases, Microbiology, and Microbiology (medical), and Q2 in Immunology—as of 2023, it positions itself as a highly reputable source in the academic community. Furthermore, its Scopus rankings highlight its significance within the respective fields, with top percentiles in key categories, making it an essential resource for researchers, professionals, and students alike. As an Open Access publication, it ensures that vital findings are accessible to a global audience, fostering collaboration and advancement in science.